Healthcare and Life Science
Ubiquigent appoints Dr Hozefa Amijee as Head of Business Development
Dundee, UK - Ubiquigent Limited, a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new therapeutics for areas of high unmet medical need, announces the appointment of Dr Hozefa Amijee as Head of Business Development (BD). ...
Alzheimer’s Research UK celebrates ‘Best Companies’ award
Cambridgeshire-based charity, Alzheimer's Research UK, has again been recognised as one of the Best Companies to work for in the East of England. ...
Optibrium and Lhasa Limited advance predictive modelling for drug-metabolising enzymes
Cambridge and Leeds – Optibrium and Lhasa Limited, two of the leading developers of software and artificial intelligence (AI) solutions for drug discovery and development, announces the publication of a peer-reviewed study in the Journal of Medicinal Chemistry. ...
How the cost of living crisis is impacting the mental wellbeing of your staff
Today (2 Nov) is Stress Awareness Day and next Monday (7 Nov) is the start of Stress Awareness Week - a time to highlight how stress can affect us and what we can do to manage it. ...
The Native Antigen Company expands its range of Omicron antigens to include BA.5 variant
New antigens support research into BA.5 variant, currently responsible for over half of global COVID-19 cases. ...
Close your open roles in 2022 with Biotech Search in 6-8 weeks
You've got time to secure talent before the holidays if you start now. We regularly work with UK Biotechs who need to supercharge their recruitment ... we guarantee our results with a 6-month free placement on your new hire. ...
Ellutia showcasing fully automated total nitrosamine testing system at Lab Innovations 2022
At Lab Innovations 2022, Ellutia will present the newest addition to its nitrosamine detection solutions, the Automated Total Nitrosamine Analyser (ATNA). The fully automated solution allows for rapid testing of apparent total nitrosamine content (ATNC) and has the right selectivity and...
Ubiquigent obtains exclusive license for UbiSite technology to strengthen its specialist drug discovery services
Dundee, UK - Ubiquigent Limited (Ubiquigent), a drug discovery and development company harnessing novel deubiquitylase (DUB) modulators as new therapeutics for areas of high unmet medical need, has signed an exclusive license with the University of Southern Denmark for its UbiSite®...
Innovate UK EDGE prepares biotech client Bilitech for Investment
Bilitech Ltd a SME based in Cambridge has developed a technology to manufacture bioengineered bile ducts in the laboratory and aims to translate it to the clinic for use in patients. Bilitech specialises in the treatment of biliary disease, focusing on the use of bioengineered bile duct...
Nuclera Nucleics Ltd grows and scale with support from Innovate UK EDGE support
With support from Innovate UK EDGE, biotech company Nuclera Nucleics were able to create a commercialisation plan, secured Series B funding and are on track to double their headcount by the end of 2022. ...